The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Identifieur interne : 000507 ( Main/Exploration ); précédent : 000506; suivant : 000508The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Auteurs : Mark R. Cookson [États-Unis]Source :
- Nature Reviews Neuroscience [ 1471-003X ] ; 2010-12.
Abstract
Parkinson's disease, like many common age-related conditions, is now recognized to have a substantial genetic component. Here, I discuss how mutations in a large complex gene — leucine-rich repeat kinase 2 (LRRK2) — affect protein function, and I review recent evidence that LRRK2 mutations affect pathways that involve other proteins that have been implicated in Parkinson's disease, specifically α-synuclein and tau. These concepts can be used to understand disease processes and to develop therapeutic opportunities for the treatment of Parkinson's disease.
Url:
DOI: 10.1038/nrn2935
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease</title>
<author><name sortKey="Cookson, Mark R" sort="Cookson, Mark R" uniqKey="Cookson M" first="Mark R." last="Cookson">Mark R. Cookson</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2A6E61C69AE50BC4A223D63F1A96E7BD0A5A40C9</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1038/nrn2935</idno>
<idno type="url">https://api.istex.fr/document/2A6E61C69AE50BC4A223D63F1A96E7BD0A5A40C9/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000218</idno>
<idno type="wicri:Area/Main/Curation">000180</idno>
<idno type="wicri:Area/Main/Exploration">000507</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease</title>
<author><name sortKey="Cookson, Mark R" sort="Cookson, Mark R" uniqKey="Cookson M" first="Mark R." last="Cookson">Mark R. Cookson</name>
<affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health (NIH), Building 35, Room 1A116, MSC 3707, 35 Convent Drive, Bethesda, 20982-3707</wicri:regionArea>
<wicri:noRegion>20982-3707</wicri:noRegion>
</affiliation>
<affiliation><wicri:noCountry code="no comma">E-mail: Cookson@mail.nih.gov</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Nature Reviews Neuroscience</title>
<idno type="ISSN">1471-003X</idno>
<idno type="eISSN">1471-0048</idno>
<imprint><publisher>Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.</publisher>
<date type="published" when="2010-12">2010-12</date>
<biblScope unit="volume">11</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="791">791</biblScope>
<biblScope unit="page" to="797">797</biblScope>
</imprint>
<idno type="ISSN">1471-003X</idno>
</series>
<idno type="istex">2A6E61C69AE50BC4A223D63F1A96E7BD0A5A40C9</idno>
<idno type="DOI">10.1038/nrn2935</idno>
<idno type="ArticleID">nrn2935</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1471-003X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="eng">Parkinson's disease, like many common age-related conditions, is now recognized to have a substantial genetic component. Here, I discuss how mutations in a large complex gene — leucine-rich repeat kinase 2 (LRRK2) — affect protein function, and I review recent evidence that LRRK2 mutations affect pathways that involve other proteins that have been implicated in Parkinson's disease, specifically α-synuclein and tau. These concepts can be used to understand disease processes and to develop therapeutic opportunities for the treatment of Parkinson's disease.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Cookson, Mark R" sort="Cookson, Mark R" uniqKey="Cookson M" first="Mark R." last="Cookson">Mark R. Cookson</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000507 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000507 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:2A6E61C69AE50BC4A223D63F1A96E7BD0A5A40C9 |texte= The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease }}
This area was generated with Dilib version V0.6.23. |